Cooley Leads HTG In Week's 2nd Diagnostics IPO
HTG Molecular Diagnostics Inc., led by Cooley LLP, went public Wednesday as the commercial stage company, which is backed by Novo A/S and Merck Capital Ventures LLC, marked the week's second...To view the full article, register now.
Already a subscriber? Click here to view full article